Analysis | Metabolite Name | Measured Value | Units | Cell Type | Stimulation |
---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (CAS# 505-95-3); (M-H)- | 2101 | Peak area | PAK | TNF-alpha |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (CAS# 505-95-3); (M-H)- | 2807 | Peak area | HAHA | IL-17A |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (CAS# 505-95-3); (M-H)- | 2839 | Peak area | PAK | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (CAS# 505-95-3); (M-H)- | 3229 | Peak area | BS4 | IFN-G |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (CAS# 505-95-3); (M-H)- | 3471 | Peak area | HAHA | TNF-alpha |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (CAS# 505-95-3); (M-H)- | 3565 | Peak area | BS4 | Untreated |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (CAS# 505-95-3); (M-H)- | 3920 | Peak area | PAK | IFN-G |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (CAS# 505-95-3); (M-H)- | 4109 | Peak area | PAK | Untreated |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (CAS# 505-95-3); (M-H)- | 4527 | Peak area | HAHA | IFN-G |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (CAS# 505-95-3); (M-H)- | 5156 | Peak area | HAHA | Untreated |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (CAS# 505-95-3); (M-H)- | 5458 | Peak area | PAK | IL-17A |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (CAS# 505-95-3); (M-H)- | 6483 | Peak area | BS4 | IL-17A |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (CAS# 505-95-3); (M-H)- | 9876 | Peak area | BS4 | TNF-alpha |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (CAS# 505-95-3); (M-H)- | 11202 | Peak area | BS4 | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (CAS# 505-95-3); (M-H)- | Peak area | HAHA | TNF-alpha+IL-17A |